甲磺酸伊马替尼治疗异基因造血干细胞移植后复发的慢性粒细胞白血病五例临床观察
出处
《中华内科杂志》
CAS
CSCD
北大核心
2006年第5期406-407,共2页
Chinese Journal of Internal Medicine
基金
国务院侨办重点学科资助项目(2005)
参考文献5
-
1Olavarria E, Craddok C, Dazzi F, et al. Imatinib mesylate( STI571 ) in the treatment of relapse of chronic myeloid leukemia after aUogeneic stem cell transplantation. Blood, 2002, 99: 3861-3862.
-
2McCann SR, Gately K, Conneally E, et al. Molecular response to Imatinib Mesylate following relapse after allogeneic SCT for CML.Blood, 2003, 101 : 1200-1201.
-
3Kantarjian HM, O' Bfien S, Cortes JE, et al. Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemia. Blood, 2002, 100 : 1590-1595.
-
4DeAngelo DJ, Hochberg EP, Alyea EP, et al. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation:durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease. Clin Cancer Res, 2004,10:5065-5071.
-
5Au WY, Lie AK, Ma SK, et al. Tyrosine kinase inhibitor STI571 in the treatment of Philadelphia chromosome-positive leukemia failing myeloablative stem cell transplantation. Bone Marrow Transplant,2002, 30:453-457.
-
1陈德福,钱林生.α干扰素在多发性骨髓瘤治疗中的应用价值[J].天津医药,2003,31(2):126-128. 被引量：1
-
2郑冬.多发性骨髓瘤的治疗现状和规范[J].临床荟萃,2014,29(10):1130-1133. 被引量：7
-
3翟明.多发性骨髓瘤的某些新治疗策略[J].白血病．淋巴瘤,2002,11(6):323-324.
-
4黄琴,王晓敏.自体造血干细胞移植治疗多发性骨髓瘤的研究进展[J].医学综述,2009,15(7):1016-1018.
-
5马丽萍,聂大年,尹松梅,谢双峰,李益清,王秀菊,吴裕丹,徐立卓.二次异体造血干细胞移植成功治疗慢性髓系白血病1例[J].中山大学学报（医学科学版）,2005,26(5). 被引量：2
-
6丁家华,陈宝安,王椿,王健民,孙耘玉,赵刚,高冲,王骏,程坚,董伟民.异基因造血干细胞移植后全血细胞减少的脾切除治疗一例报告并文献复习[J].中华血液学杂志,2004,25(2):123-124. 被引量：3
-
7陈昀（综述）,沈志祥（审校）.多发性骨髓瘤治疗进展[J].国际肿瘤学杂志,2007,34(10):785-788.
-
8薛军.多发性骨髓瘤化疗的新策略[J].中华全科医学,2009,7(11):1231-1233. 被引量：4
-
9翟卫华,冯四洲.自体造血干细胞移植治疗多发性骨髓瘤[J].国外医学（输血及血液学分册）,2003,26(5):396-399.
-
10贾玖丽,马晓欣,柯孝瑜.阿霉素联合他莫昔芬对人子宫内膜癌裸鼠移植瘤的抑制作用[J].现代肿瘤医学,2013,21(11):2423-2427. 被引量：2
